Apple vs Bausch Health: Founders, CEOs and History

Company facts

Founders

CEOs and their tenures

Timeline: Apple and Bausch Health side by side

1. 1959Bausch Health

   Milan Panic founds ICN Pharmaceuticals

   Milan Panic, a Yugoslav immigrant to California, founded ICN Pharmaceuticals in 1959 and ran it for four decades. ICN is the predecessor of Valeant Pharmaceuticals and of today's Bausch Health.

2. 1976Apple

   Apple is founded by Steve Jobs, Steve Wozniak, and Ronald Wayne, turning an early personal-computer board into a company with a product and a market.

   Steve Jobs, Steve Wozniak, and Ronald Wayne founded Apple in 1976, when personal computing was still a hobbyist market.

3. 1977Apple

   The Apple II launches and gives the young company an expandable personal computer for schools, homes, and small businesses.

   The Apple II turned a garage project into a business. Color graphics, expansion slots and a consumer-friendly design carried it into schools, homes and small offices, giving Apple a revenue base years before the Macintosh.

4. 1980Apple

   Apple completes its initial public offering in December 1980, raising capital and turning personal computing into a public-market story.

   The December 1980 IPO gave Apple public-market capital and made personal computing look like a serious commercial category. It also raised the pressure to professionalize management, distribution and product planning as the company outgrew its founding team.

5. 1984Apple

   The Macintosh introduces a graphical interface and mouse-driven computing to a broad audience at a $2,495 launch price.

   The Macintosh brought a graphical interface and a mouse to a mass-market computer and defined Apple's design identity.

6. 1994Bausch Health

   Biovail Corporation International formed in Canada

   On March 29, 1994 Eugene Melnyk consolidated his Canadian drug-delivery business by amalgamating Trimel Corporation with its subsidiary to create Biovail Corporation International, the legal entity that files today as Bausch Health Companies Inc.

7. 1997Apple

   Apple completes the NeXT acquisition, bringing Steve Jobs back and supplying the operating-system foundation for the years that followed.

   Apple's NeXT acquisition brought Steve Jobs back when the company was financially weak and unfocused.

8. 2001Apple

   Apple introduces the iPod on October 23, 2001, a 5GB music player priced at $399 that held about 1,000 songs.

   The iPod put a hard-drive music library in a pocket at $399 and went on sale on November 10, 2001.

9. 2003Bausch Health

   ICN renames itself Valeant Pharmaceuticals

   ICN Pharmaceuticals, then based in Costa Mesa, California, took the Valeant Pharmaceuticals name in November 2003 to distance itself from the governance fights of the Panic era.

10. 2007Apple

    The iPhone is introduced as a phone, widescreen iPod, and internet communicator, moving Apple into the center of mobile computing.

    The iPhone moved Apple into mobile computing and shifted the company's center of gravity away from the Mac. It also created the hardware base that later supported services, accessories and developer economics.

11. 2008Apple

    The App Store opens with 500 apps, creating a controlled software marketplace that becomes a major Services pillar.

    The App Store launched with 500 apps and gave iPhone owners a single, controlled way to install third-party software.

12. 2008Bausch Health

    J. Michael Pearson becomes chief executive

    Valeant appointed former McKinsey director J. Michael Pearson as chief executive effective February 1, 2008, succeeding Timothy C. Tyson. Pearson replaced internal research spending with debt-funded acquisitions of marketed drugs.

13. 2010Bausch Health

    Biovail and Valeant complete their merger

    The merger of Biovail Corporation and Valeant Pharmaceuticals International closed on September 28, 2010. The combined company kept the Valeant name and Pearson as chief executive but was incorporated in Canada.

14. 2011Apple

    Tim Cook becomes chief executive on August 24, 2011, after Steve Jobs resigns and the board names Cook to succeed him.

    Apple's board named Tim Cook chief executive on August 24, 2011, when Steve Jobs resigned and recommended the succession plan be carried out.

15. 2011Bausch Health

    Ortho Dermatologics bought from Johnson and Johnson

    Valeant agreed to acquire the U.S. Ortho Dermatologics assets from Janssen Pharmaceuticals, a Johnson and Johnson company, for about $345M in cash, building the dermatology franchise.

16. 2013Bausch Health

    Bausch + Lomb acquired for $8.7 billion

    Valeant agreed in May 2013 to buy eye-health company Bausch + Lomb from Warburg Pincus for $8.7B in cash, adding contact lenses, lens care, ophthalmic drugs and surgical devices.

17. 2014Apple

    Apple agrees to acquire Beats Music and Beats Electronics for $3 billion, its largest deal.

    Apple agreed to buy Beats Music and Beats Electronics for a total of $3 billion, about $2.6 billion in purchase price plus roughly $400 million vesting over time, and brought in founders Jimmy Iovine and Dr. Dre.

18. 2015Bausch Health

    Salix acquisition closes at about $11.1 billion

    Valeant completed its tender offer for Salix Pharmaceuticals on April 1, 2015 at $173 per share, about $11.1B in equity value and roughly $15.8B including debt, gaining the Xifaxan franchise.

19. 2015Bausch Health

    Drug pricing and Philidor scandal breaks

    Congressional investigators pressed Valeant over 525% and 212% increases on the heart drugs Isuprel and Nitropress, bought in February 2015, and over its undisclosed ties to the Philidor mail-order pharmacy.

20. 2016Bausch Health

    Joseph Papa replaces Pearson as chief executive

    Valeant named Perrigo chief executive Joseph C. Papa as chairman and CEO on April 25, 2016, and he took over in early May 2016 with about $30B of debt outstanding.

21. 2017Bausch Health

    Skincare brands and Dendreon sold to cut debt

    Valeant sold the CeraVe, AcneFree and AMBI skincare brands to L'Oreal for about $1.3B and the Dendreon cancer unit to China's Sanpower Group for about $820M, using the proceeds to repay debt.

22. 2018Bausch Health

    Company renamed Bausch Health Companies Inc.

    The name change from Valeant Pharmaceuticals International, Inc. to Bausch Health Companies Inc. was completed on July 13, 2018, and the shares began trading as BHC on the NYSE and TSX on July 16, 2018.

23. 2020Apple

    Apple announces the Mac transition to Apple silicon, deepening control over performance, power efficiency, and software optimization.

    Apple began moving Mac computers off Intel processors and onto its own M-series chips in 2020.

24. 2020Bausch Health

    SEC settlement closes the Philidor accounting case

    On July 31, 2020 Bausch Health agreed to pay a $45M civil penalty to settle SEC charges of improper revenue recognition and misleading disclosures tied to Philidor. Former chief executive J. Michael Pearson and two other executives also settled.

25. 2022Bausch Health

    Bausch + Lomb listed on the NYSE and TSX

    Bausch + Lomb common stock began trading under the ticker BLCO on May 6, 2022, and a Bausch Health subsidiary sold 35,000,000 Bausch + Lomb shares in the offering. Bausch Health retained about 88% of the eye-health company and still consolidates it. Thomas J.

26. 2024Apple

    Vision Pro launches at $3,499 and gives Apple a shipping platform for spatial interfaces, sensors, and custom silicon.

    Vision Pro gave Apple a live platform for spatial interfaces, eye and hand input, high-resolution displays and custom chips.

27. 2025Bausch Health

    DURECT acquired and record annual revenue reported

    Bausch Health closed the DURECT acquisition on September 11, 2025 for about $63M upfront, completed Solta Medical's Chinese aesthetics distribution purchase on December 1, 2025, and reported FY2025 revenue of $10.266B, up 7%, with net income attributable to Ba…

28. 2026Apple

    John Ternus becomes chief executive on September 1, 2026, and Tim Cook becomes executive chairman.

    John Ternus, Apple's senior vice president of Hardware Engineering, became chief executive on September 1, 2026, and Tim Cook became executive chairman after 15 years as CEO.

29. 2026Bausch Health

    RED-C trials miss endpoints and trigger a $1.4 billion charge

    In January 2026 the two Phase 3 RED-C trials of amorphous-rifaximin soluble solid dispersion for primary prevention of hepatic encephalopathy missed their primary endpoints.

30. 2026Bausch Health

    Second-quarter 2026 revenue of $2.85 billion and raised guidance

    Bausch Health reported second-quarter 2026 revenue of $2.85B, up 13%, net income attributable to Bausch Health of $258M and adjusted EBITDA of $1.075B, and raised its full-year 2026 revenue, adjusted EBITDA and cash flow guidance.

Acquisitions

Questions about Apple vs Bausch Health